221 related articles for article (PubMed ID: 11334367)
1. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Bitisik O; Yavuz S; Yasasever V; Dalay N
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
3. Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Keller G; Brassat U; Braig M; Heim D; Wege H; Brümmendorf TH
Hematol Oncol; 2009 Sep; 27(3):123-9. PubMed ID: 19569255
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
6. [Telomeres, telomerase and development of cancer].
Andersen TI
Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
[TBL] [Abstract][Full Text] [Related]
7. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
8. In vivo regulation of telomerase activity and telomere length.
Hathcock KS; Jeffrey Chiang Y; Hodes RJ
Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348
[TBL] [Abstract][Full Text] [Related]
9. Multiple pathways for the regulation of telomerase activity.
Holt SE; Wright WE; Shay JW
Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
[TBL] [Abstract][Full Text] [Related]
10. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
[TBL] [Abstract][Full Text] [Related]
11. A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias.
Tatematsu K; Nakayama J; Danbara M; Shionoya S; Sato H; Omine M; Ishikawa F
Oncogene; 1996 Nov; 13(10):2265-74. PubMed ID: 8950994
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
13. Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
Hartmann U; Balabanov S; Ziegler P; Fellenberg J; van der Kuip H; Duyster J; Lipp HP; Bokemeyer C; Kanz L; Brümmendorf TH
Exp Hematol; 2005 May; 33(5):542-9. PubMed ID: 15850831
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and telomere detection during early bovine development.
Betts DH; King WA
Dev Genet; 1999; 25(4):397-403. PubMed ID: 10570471
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
16. Telomere reduction and telomerase inactivation during neuronal cell differentiation.
Kruk PA; Balajee AS; Rao KS; Bohr VA
Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416
[TBL] [Abstract][Full Text] [Related]
17. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.
Brassat U; Balabanov S; Bali D; Dierlamm J; Braig M; Hartmann U; Sirma H; Günes C; Wege H; Fehse B; Gontarewicz A; Dikomey E; Borgmann K; Brümmendorf TH
Exp Hematol; 2011 Jan; 39(1):66-76.e1-2. PubMed ID: 20940029
[TBL] [Abstract][Full Text] [Related]
18. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase in normal and malignant haematopoietic cells.
Norrback KF; Roos G
Eur J Cancer; 1997 Apr; 33(5):774-80. PubMed ID: 9282116
[TBL] [Abstract][Full Text] [Related]
20. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
